Sir -We thank Drs David and Sobrinho-Simoes for their interest in our article. Tenascin is a multifunctional glycoprotein participating in an integral part of the normal matrix, inflammation and embryogenesis. Tenascin was found to be immunohistochemically expressed in the muscularis mucosae or muscularis propria of normal tissue in both the stomach (Ikeda et al., 1995) and colon (Riedl et al., 1992; Sakai et al., 1993) , as well as in inflammatory lesions of the colon (Riedl et al., 1992) . However, in these tissues tenascin was expressed only weakly or moderately. Tenascin is also produced during wound healing (Mackie et al., 1987) , and the granulation tissue of peptic ulcers, which was not evaluated in this study, may also induce the production of tenascin. As suggested by David and Sobrinho-Simoes, the expression of tenascin in non-cancerous lesions still needs to be analysed. There is also increasing evidence that tenascin plays an important role in the oncofetal potential such as that seen in tumour invasion or metastasis. Tenascin is induced by transforming growth factor beta (TGF-fl) (Chiquet-Ehnrsmann et al., 1989) , and is composed of paracentral epidermal growth factor (EGF)-like repeats (Jones et al., 1988) .
Previous studies have consistently reported that tenascin was markedly expressed in the tissue of malignant tumours (Howeedy et al., 1990; Riedl et al., 1992; Sakai et al.. 1993 Computerised tomography (CT) scans from all patients referred to one of us (PS) with metastatic germ cell cancer who completed treatment with cisplatin-based cytotoxic chemotherapy between 1980 and 1990 have been reviewed with particular attention to assessing the degree of thymic hyperplasia in the post-chemotherapy period. Any patient in whom obvious enlargement was visible was considered to be positive. There was little difficulty in recognising the shadow.
As part of an assessment of effect of treatment on fertility all patients had serial readings of luteinising hormone (LH). recorded before treatment, at 3 months after starting treatment and at every attendance thereafter during the following 5 years.
During the 10 year period under review, 236 patients were entered into departmental studies. Review of CT scans revealed 23 with thymic enlargement, three of whom had the nature of the swelling confirmed at thoracotomy ( Figure   1 ).
Four of 23 patients with thymic hyperplasia and only 1 of 37 disease extent-and age-matched germ cell cancer patient controls selected randomly for hormone studies from the 199 without thymic hyperplasia had undergone bilateral orchidectomy before treatment. 
